Antibiotic resistance has long been understood as a population-level phenomenon, but witnessing its real-time evolution within a single patient's microbiome represents a paradigm shift in how clinicians might approach personalized antimicrobial therapy. This granular view of bacterial adaptation could transform treatment strategies from broad-spectrum approaches to precision interventions.
Using single-cell sequencing on gut samples from a hospitalized stroke patient, researchers tracked 92 bacterial species as they adapted to antibiotic pressure. The analysis revealed 29 distinct antibiotic resistance gene subtypes distributed across 36 species, with the cfr(C) resistance gene appearing in 11 different bacterial species during treatment. Perhaps most concerning, 309 horizontal gene transfer events were documented, including frequent exchanges of DNA repair genes like folE and queE that help bacteria survive antibiotic assault. Two distinct Klebsiella pneumoniae strains were identified, with one showing extensive resistance gene co-evolution.
This single-patient deep dive illuminates why antibiotic treatments often fail despite initial sensitivity testing. Traditional culture methods miss the microbial dark matter—the unclassified species that comprised most detected organisms here. The real-time documentation of resistance gene migration between species suggests that even narrow-spectrum antibiotics create selective pressure across the entire microbiome ecosystem. While this represents just one patient's microbial story, the methodology offers a potential clinical tool for predicting treatment failure and optimizing antibiotic selection. However, the complexity and cost of single-cell sequencing currently limit its clinical applicability beyond research settings.